188 related articles for article (PubMed ID: 17245338)
1. Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer.
Chiarion-Sileni V; Corti L; Ruol A; Innocente R; Boso C; Del Bianco P; Pigozzo J; Mazzarotto R; Tomassi O; Ancona E
Br J Cancer; 2007 Feb; 96(3):432-8. PubMed ID: 17245338
[TBL] [Abstract][Full Text] [Related]
2. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
Satake H; Tahara M; Mochizuki S; Kato K; Hara H; Yokota T; Kiyota N; Kii T; Chin K; Zenda S; Kojima T; Bando H; Yamazaki T; Iwasa S; Honma Y; Hamauchi S; Tsushima T; Ohtsu A
Cancer Chemother Pharmacol; 2016 Jul; 78(1):91-9. PubMed ID: 27193097
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel and cisplatin concurrent with radiotherapy versus 5-fluorouracil and cisplatin concurrent with radiotherapy in treatment for locally advanced oesophageal squamous cell carcinoma: a randomized clinical study.
Zhao T; Chen H; Zhang T
Med Oncol; 2012 Dec; 29(5):3017-23. PubMed ID: 22476809
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced oesophageal cancer.
Shim HJ; Kim DE; Hwang JE; Bae WK; Nam TK; Na KJ; Cho SH; Chung IJ
Cancer Chemother Pharmacol; 2012 Nov; 70(5):683-90. PubMed ID: 22932694
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer.
Yokota T; Kato K; Hamamoto Y; Tsubosa Y; Ogawa H; Ito Y; Hara H; Ura T; Kojima T; Chin K; Hironaka S; Kii T; Kojima Y; Akutsu Y; Matsushita H; Kawakami K; Mori K; Nagai Y; Asami C; Kitagawa Y
Br J Cancer; 2016 Nov; 115(11):1328-1334. PubMed ID: 27811857
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer.
Day FL; Leong T; Ngan S; Thomas R; Jefford M; Zalcberg JR; Rischin D; McKendick J; Milner AD; Di Iulio J; Matera A; Michael M
Br J Cancer; 2011 Jan; 104(2):265-71. PubMed ID: 21157450
[TBL] [Abstract][Full Text] [Related]
7. Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma.
Hara H; Tahara M; Daiko H; Kato K; Igaki H; Kadowaki S; Tanaka Y; Hamamoto Y; Matsushita H; Nagase M; Hosoya Y
Cancer Sci; 2013 Nov; 104(11):1455-60. PubMed ID: 23991649
[TBL] [Abstract][Full Text] [Related]
8. High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy.
Pasini F; de Manzoni G; Pedrazzani C; Grandinetti A; Durante E; Gabbani M; Tomezzoli A; Griso C; Guglielmi A; Pelosi G; Maluta S; Cetto GL; Cordiano C
Ann Oncol; 2005 Jul; 16(7):1133-9. PubMed ID: 15946974
[TBL] [Abstract][Full Text] [Related]
9. Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus.
Damle S; Beitler JJ; Haynes H; Camacho M; Wolf E; Wadler S
Am J Clin Oncol; 1999 Aug; 22(4):391-5. PubMed ID: 10440197
[TBL] [Abstract][Full Text] [Related]
10. [Comparison between docetaxel plus cisplatin and cisplatin plus fluorouracil in the neoadjuvant chemoradiotherapy for local advanced esophageal squamous cell carcinoma].
Wu S; Chen MY; Luo JC; Wei L; Chen Z
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):873-6. PubMed ID: 23291141
[TBL] [Abstract][Full Text] [Related]
11. Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).
Higuchi K; Komori S; Tanabe S; Katada C; Azuma M; Ishiyama H; Sasaki T; Ishido K; Katada N; Hayakawa K; Koizumi W;
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):872-9. PubMed ID: 24867539
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1).
Oertel K; Spiegel K; Schmalenberg H; Dietz A; Maschmeyer G; Kuhnt T; Sudhoff H; Wendt TG; Guntinas-Lichius O
BMC Cancer; 2012 Oct; 12():483. PubMed ID: 23083061
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: a phase 2 study.
Pasini F; de Manzoni G; Zanoni A; Grandinetti A; Capirci C; Pavarana M; Tomezzoli A; Rubello D; Cordiano C
Cancer; 2013 Mar; 119(5):939-45. PubMed ID: 23165781
[TBL] [Abstract][Full Text] [Related]
14. Trimodality therapy for stage II-III carcinoma of the esophagus: a dose-ranging study of concurrent capecitabine, docetaxel, and thoracic radiotherapy.
Wood MD; Zaki BI; Gordon SR; Sutton JE; Lisovsky M; Gui J; Bubis JA; Dragnev KH; Rigas JR
J Thorac Oncol; 2013 Apr; 8(4):487-94. PubMed ID: 23370365
[TBL] [Abstract][Full Text] [Related]
15. Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma.
Ma HB; Di ZL; Wen J; Ke Y; Sun X; Ren J
Jpn J Clin Oncol; 2015 Feb; 45(2):169-75. PubMed ID: 25416813
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.
Schrijvers D; Van Herpen C; Kerger J; Joosens E; Van Laer C; Awada A; Van den Weyngaert D; Nguyen H; Le Bouder C; Castelijns JA; Kaanders J; De Mulder P; Vermorken JB
Ann Oncol; 2004 Apr; 15(4):638-45. PubMed ID: 15033673
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck.
Tsukuda M; Mikami Y; Tanigaki Y; Katori H; Horiuchi C; Ikeda Y; Taguchi T; Ono M; Yoshida T; Sakuma Y; Aikoh K
Int J Clin Oncol; 2004 Jun; 9(3):161-6. PubMed ID: 15221599
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
19. Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT)
Sakai M; Sohda M; Saito H; Nakazawa N; Ubukata Y; Kuriyama K; Hara K; Sano A; Ogawa H; Yokobori T; Murata K; Noda SE; Ohno T; Shirabe K; Saeki H
Anticancer Res; 2021 Apr; 41(4):2141-2145. PubMed ID: 33813425
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02).
Ruhstaller T; Widmer L; Schuller JC; Roth A; Hess V; Mingrone W; von Moos R; Borner M; Pestalozzi BC; BalmerMajno S; Köberle D; Terraciano L; Schnider A; Bodis S; Popescu R;
Ann Oncol; 2009 Sep; 20(9):1522-1528. PubMed ID: 19465425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
